UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 20,832.8% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 6,217,474 shares of the real estate investment trust's stock after acquiring an additional 6,187,772 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.90% of Healthpeak Properties worth $133,054,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. New York Life Investment Management LLC boosted its holdings in shares of Healthpeak Properties by 65.8% in the fourth quarter. New York Life Investment Management LLC now owns 156,086 shares of the real estate investment trust's stock valued at $2,510,000 after buying an additional 61,952 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al raised its holdings in shares of Healthpeak Properties by 176.0% during the fourth quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 320,040 shares of the real estate investment trust's stock worth $5,146,000 after acquiring an additional 204,100 shares during the period. Swedbank AB lifted its position in Healthpeak Properties by 433.4% in the 4th quarter. Swedbank AB now owns 849,215 shares of the real estate investment trust's stock valued at $13,655,000 after acquiring an additional 690,000 shares in the last quarter. Nan Fung Trinity HK Ltd. bought a new stake in Healthpeak Properties in the 4th quarter valued at $2,654,000. Finally, JPMorgan Chase & Co. boosted its stake in Healthpeak Properties by 8.6% in the 4th quarter. JPMorgan Chase & Co. now owns 30,674,812 shares of the real estate investment trust's stock worth $493,251,000 after purchasing an additional 2,438,278 shares during the period. 93.57% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of research firms have issued reports on DOC. Cantor Fitzgerald increased their target price on Healthpeak Properties from $20.00 to $23.00 and gave the stock a "neutral" rating in a report on Thursday, August 6th. Mizuho boosted their price target on Healthpeak Properties from $21.00 to $24.00 and gave the company an "outperform" rating in a report on Monday, July 6th. UBS Group upped their price objective on Healthpeak Properties from $19.00 to $21.50 and gave the stock a "neutral" rating in a research report on Wednesday, July 8th. Barclays lifted their target price on Healthpeak Properties from $23.00 to $24.00 and gave the company an "equal weight" rating in a research report on Monday. Finally, Scotiabank upped their price target on Healthpeak Properties from $19.00 to $21.00 and gave the stock a "sector perform" rating in a research report on Wednesday, May 27th. Four analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $21.72.
Read Our Latest Report on Healthpeak Properties
Healthpeak Properties Stock Performance
DOC opened at $20.80 on Wednesday. The business's 50-day simple moving average is $21.57 and its 200 day simple moving average is $19.25. Healthpeak Properties, Inc. has a 52-week low of $15.70 and a 52-week high of $22.95. The company has a debt-to-equity ratio of 1.06, a quick ratio of 3.02 and a current ratio of 3.02. The firm has a market capitalization of $14.34 billion, a PE ratio of 59.43, a PEG ratio of 2.27 and a beta of 1.01.
Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its quarterly earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share for the quarter, beating analysts' consensus estimates of $0.03 by $0.05. Healthpeak Properties had a return on equity of 2.79% and a net margin of 8.24%.The firm had revenue of $771.58 million during the quarter, compared to the consensus estimate of $725.64 million. During the same period last year, the company earned $0.46 earnings per share. The business's revenue was up 11.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. As a group, sell-side analysts expect that Healthpeak Properties, Inc. will post 1.77 earnings per share for the current fiscal year.
Healthpeak Properties Dividend Announcement
The company also recently announced a monthly dividend, which will be paid on Friday, September 25th. Investors of record on Monday, September 14th will be paid a $0.1017 dividend. The ex-dividend date of this dividend is Monday, September 14th. This represents a c) annualized dividend and a dividend yield of 5.9%. Healthpeak Properties's dividend payout ratio (DPR) is currently 348.57%.
Healthpeak Properties Company Profile
(
Free Report)
Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.
Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.
Featured Stories
Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOC - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
